Publications

Reneo Pharmaceuticals Research

PittGene Meeting

Click to view

Clinical Manifestations and Disease Burden of Primary Mitochondrial Myopathies (PMM): Results from a Patient Journey Analysis Shows Substantial Healthcare Resource Utilization

Click to view

Predictive Physiologically Based Pharmacokinetic (PBPK) Model Suggests Minimal Drug-Drug Interaction (DDI) Between PPARδ Agonist Mavodelpar (REN001) & Rosuvastatin

Click to view

Mavodelpar Clinical Development Program in Adult Patients with Primary Mitochondrial Myopathies: Results from a Phase 1b Study and Design of Ongoing Pivotal Study (STRIDE)

Click to view

Reneo Pharmaceuticals Clinical Trial Update Presentation

Click to view